A 2018 study in HCC cells showed that CNPY2 interacts directly with the tumor microenvironment, including various immune cells, such as T cells, as well as extracellular proteins and cytokines that contribute to HCC proliferation [2]. Here, CNPY2 is linked to hepatocellular carcinoma.